Covid-19 Clinical Trials

A listing of Covid-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 268 clinical trials
Safety Tolerability and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

This is a phase 1 study in which healthy adult volunteers will receive BRII-198 or placebo and will be assessed for safety, tolerability, and pharmacokinetics.

body mass index
monoclonal antibodies
  • 0 views
  • 19 Feb, 2024
Efficacy and Safety of Mucoadhesive Sustained Release Mucodentol in Comparison With Hydroxychloroquine to Prevent COVID-19

180 people from the medical staff and high-risk people in Baqiyatallah Hospital, who are in close contact with patients, will enter the study. Participants will be divided into two intervention groups and one control group. The control group will use the full protective equipment assigned to the treatment staff. In …

hydroxychloroquine
throat
covid-19
  • 0 views
  • 19 Feb, 2024
Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

In vitro study have shown its activity against SARS-CoV-2, however its clinical effect on patients with COVID-19 never been tested. In this RCT we would like to evaluate the effect of Ivermectin on reduction of viral shedding among mild to moderate COVID-19 patients, and in shortening the symptom resolution time.

SARS
ivermectin
acute respiratory syndrome (sars)
viral shedding
covid-19
  • 0 views
  • 19 Feb, 2024
Safety Tolerability and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

This is a phase 1 study in which healthy adult volunteers will receive BRII-196 or placebo and will be assessed for safety, tolerability, and pharmacokinetics.

body mass index
monoclonal antibodies
  • 0 views
  • 19 Feb, 2024
Study of the Efficacy and Safety of Intravenous Pamrevlumab in Hospitalized Patients With Acute COVID-19 Disease

This is a Phase 2 trial to evaluate the efficacy and safety of intravenous (IV) infusions of pamrevlumab as compared to placebo in hospitalized subjects with acute COVID-19 disease.

mechanical ventilation
SARS
acute respiratory syndrome (sars)
pneumonia
extracorporeal membrane oxygenation
  • 0 views
  • 19 Feb, 2024
Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)

This analysis can be done by the technique of electronic nose, simpler and faster, which provides an idea of the general profile of the VOCs without identifying them. The VOCs in exhaled air in patients hospitalized for COVID-19 infection are analysed in this study, using electronic noses.

respiratory disorder
SARS
volatile organic compounds
acute respiratory syndrome (sars)
covid-19
  • 0 views
  • 19 Feb, 2024
Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

The HCW Prophylaxis (HCWP) Study, single, open and off label intervention study. Up to 350 participants will be assigned to group that takes HCQ or group that opts to not take study medication. Participants will be UNM HEALTH SYSTEM HCW at high risk for occupational exposure to SARSCoV- 2. Study …

hydroxychloroquine
occupational exposure
SARS
acute respiratory syndrome (sars)
covid-19
  • 0 views
  • 19 Feb, 2024
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19

This study is a multi-center randomized, controlled, and blinded clinical trial study that will be performed in four medical-educational centers. In this study, the samples will be selected from among patients with SARS-CoV-2 as easy access and based on entry criteria and will be randomly divided into two groups, including …

dyspnea
SARS
covid-19
acute respiratory syndrome (sars)
ct scan
  • 0 views
  • 19 Feb, 2024
Study to Evaluate the Safety Tolerability Pharmacokinetics and Efficacy of Remdesivir (GS-5734 ) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)

The primary objectives of this study are to evaluate the safety, tolerability, and pharmacokinetics (PK) of remdesivir (RDV) in participants with laboratory-confirmed coronavirus disease 2019 (COVID-19) aged 0 days to < 18 years.

remdesivir
PCR test
SARS
acute respiratory syndrome (sars)
coronavirus infection
  • 0 views
  • 19 Feb, 2024
Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19

This is an open label pilot study designed to provide access to treatment with investigational convalescent plasma and assess the relationship between NAb titers in the investigational convalescent plasma compared to changes in NAb levels in the recipient in hospitalized patients with COVID-19.

acute respiratory syndrome (sars)
covid-19
respiratory symptom
  • 0 views
  • 19 Feb, 2024